Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TTNP - Titan Pharmaceuticals, Inc. (de)


IEX Last Trade
5.97
0.307   5.134%

Share volume: 148,836
Last Updated: Fri 30 Aug 2024 05:46:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$5.66
0.31
5.41%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023
Report Date 2022-05-16 2022-08-11 2022-11-14 2023-03-31 2023-05-15
Assets
Total Assets 10.318 M 8.319 M 6.276 M 4.058 M 2.168 M
Current Assets 9.633 M 7.713 M 5.747 M 3.603 M 1.785 M
Inventories 293.000 K 469.000 K 460.000 K 106.000 K 106.000 K
Other Current Assets 749.000 K 544.000 K 512.000 K 314.000 K 406.000 K
Short Term Investments 749.000 K 544.000 K 512.000 K 314.000 K 406.000 K
Total Receivables 218.000 K 101.000 K 49.000 K 36.000 K 8.000 K
Current Cash 8.138 M 6.420 M 4.450 M 2.937 M 1.136 M
Total Non-current Assets 685.000 K 606.000 K 529.000 K 455.000 K 383.000 K
Property Plant Equipment 368.000 K 317.000 K 269.000 K 224.000 K 181.000 K
Other Assets 48.000 K 48.000 K 48.000 K 48.000 K 48.000 K
Intangible Assets 0.000 0.000 0.000 0.000 0.000
Goodwill 0.000 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 10.318 M 8.319 M 6.276 M 4.058 M 2.168 M
Total liabilities 2.436 M 2.652 M 2.726 M 2.695 M 2.480 M
Total current liabilities 2.278 M 2.524 M 2.630 M 2.630 M 2.447 M
Accounts Payable 468.000 K 443.000 K 812.000 K 695.000 K 567.000 K
Other liabilities 0.000 0.000 0.000 0.000 0.000
Current long term debt 0.000 0.000 0.000 0.000 0.000
Long term debt 0.000 0.000 0.000 0.000 0.000
Other liabilities 0.000 0.000 0.000 0.000 0.000
Minority interest 0.000 0.000 0.000 0.000 0.000
Total Shareholder equity 7.882 M 5.667 M 3.550 M 1.363 M -312.000 K
Common stock 10.729 M 13.692 M 14.629 M 14.686 M 15.016 M
Retained earnings -378.595 M -381.057 M -383.695 M -386.261 M -387.936 M